Skip to main content
Clinical Trials/NCT05792111
NCT05792111
Recruiting
Phase 4

Analgesic Effects of Trigger Point Injection Added to Caudal Epidural Steroid

Abant Izzet Baysal University1 site in 1 country72 target enrollmentOctober 12, 2022

Overview

Phase
Phase 4
Intervention
Caudal epidural Group (bupivacaine + triamcinolone + NaCl)
Conditions
Myofascial Trigger Point Pain
Sponsor
Abant Izzet Baysal University
Enrollment
72
Locations
1
Primary Endpoint
Numerical Rating Scale (NRS) score
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90

Detailed Description

Demographic information of all patients included in the study; name, surname, telephone number, age, gender, educational status, profession, and marital status will be recorded. The duration of the pain, the onset of the pain, the accompanying leg pain, the activities that increase or decrease the pain, the presence of neurological symptoms, the analgesic agents used in the last week, and the previous treatments will be noted. Lumbar MRI findings and the level of pathology causing low back and hip pain will be recorded. History, family history, comorbidities (hypertension, diabetes mellitus, hyperlipidemia, cardiac disease, hypothyroidism), and detailed physical examinations of the patients will be recorded. Examinations of the patients before and 3, 6, and 12 weeks after the injection will be performed, and NRS scores at 3 and 6 weeks. The procedures will be repeated for patients who are over 4 years old. During the pre-procedural evaluation, the patients will be informed about the study, information about the Numeric Rating Score (NRS), Oswestry Disability Index (ODI), Short Form-36 (SF-36) to be used for post-procedure analgesia, and both verbal and written consents will be obtained. The staff who will make the evaluation will not know which group the patients belong to, and the study will be blinded.

Registry
clinicaltrials.gov
Start Date
October 12, 2022
End Date
December 20, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Murat Bilgi

Prof.dr

Abant Izzet Baysal University

Eligibility Criteria

Inclusion Criteria

  • Low back or leg pain that has been going on for at least 2 months,
  • Patients between the ages of 18-70,
  • Disc herniation or radiculopathy in lumbar MRI examination .To be mentally competent to understand and evaluate NRS, ODI, and SF-36 forms.
  • exclusion criteria
  • Being pregnant or lactating,
  • Presence of spinal canal stenosis,
  • The presence of bleeding diathesis,
  • Presence of disease with progressive neurological deficit,
  • The presence of serious psychiatric illness,
  • Presence of progressive neurological deficit or incontinence,

Exclusion Criteria

  • Not provided

Arms & Interventions

Group C

Group C; caudal epidural steroid injection (10 mL volume of bupivacaine 4cc/20mg+ triamcinolone 2cc/80mg+0.09% NaCl 4cc mixture will be administered into the caudal epidural space).

Intervention: Caudal epidural Group (bupivacaine + triamcinolone + NaCl)

Group CT

Group CT; trigger point injection will be added to the gluteus medius and minimus muscles in addition to caudal epidural steroid injection.

Intervention: Trigger point injection (lidocaine)

Group CT

Group CT; trigger point injection will be added to the gluteus medius and minimus muscles in addition to caudal epidural steroid injection.

Intervention: Caudal epidural Group (bupivacaine + triamcinolone + NaCl)

Outcomes

Primary Outcomes

Numerical Rating Scale (NRS) score

Time Frame: after ESİ12 weeks

NRS score measures a patient's pain intensity. For example, (range 0-10) where 0 is no pain and 10 is the worst pain

Secondary Outcomes

  • Oswestry Disability Index(after ESİ12 weeks)
  • Short Form-36(after ESİ12 weeks)

Study Sites (1)

Loading locations...

Similar Trials